A Study Comparing the Effectiveness and Safety of Varying Dose Strengths (100, 200, 300 and 400 mg) of Extended-release Tramadol HCl With Placebo for the Treatment of Osteoarthritis(OA) of the Knee and/or Hip
PHASE3CompletedINTERVENTIONAL
Enrollment
1,000
Participants
Timeline
Start Date
January 31, 2002
Study Completion Date
December 31, 2003
Conditions
Chronic Pain
Interventions
DRUG
Tramadol HCl ER
Trial Locations (1)
16635
Altoona Center for Clinical Research, Duncansville
All Listed Sponsors
lead
Bausch Health Americas, Inc.
INDUSTRY
NCT00325858 - A Study Comparing the Effectiveness and Safety of Varying Dose Strengths (100, 200, 300 and 400 mg) of Extended-release Tramadol HCl With Placebo for the Treatment of Osteoarthritis(OA) of the Knee and/or Hip | Biotech Hunter | Biotech Hunter